Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel · Delayed Price · Currency is ILS · Price in ILA 21.60
-0.50 (-2.26%)
Oct 23, 2026, 1:44 PM IDT
TLV:CBI Market Cap
TLV:CBI has a market cap or net worth of 33.88 million as of October 23, 2026. It is the 40,825th most valuable company in the world and the 435th biggest in Israel. Its market cap has decreased by 32.29% in one year.
Market Cap
33.88M
Enterprise Value
50.84M
Revenue
n/a
Global Rank
Country Rank
#435 Israel
PE Ratio
n/a
ChartMarket Cap Chart
Since July 23, 2007, TLV:CBI's market cap has decreased from 797.05M to 33.88M, a decrease of -95.75%. That is a compound annual growth rate of -15.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 33.88M | -28.95% |
| Dec 31, 2025 | 47.68M | -12.89% |
| Dec 31, 2024 | 54.74M | -12.09% |
| Dec 31, 2023 | 62.27M | -36.78% |
| Dec 29, 2022 | 98.50M | -46.87% |
| Dec 30, 2021 | 185.39M | -41.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 210.26M |
| Matricelf | 81.24M |
| BioLineRx | 32.86M |
| Purple Biotech | 32.42M |
| BioLight Life Sciences | 27.20M |
| XTL Biopharmaceuticals | 19.87M |
| Can-Fite BioPharma | 18.39M |
| Evogene | 17.92M |